サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1605699

コネクテッドドラッグデリバリーデバイスの世界市場：製品種類別・用途別・投与経路別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2024年～2032年)

Connected Drug Delivery Devices Market, By Product Type, By Application, Route of Administration, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 388 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
コネクテッドドラッグデリバリーデバイスの世界市場：製品種類別・用途別・投与経路別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2024年～2032年)
出版日: 2024年12月01日
発行: AnalystView Market Insights
ページ情報: 英文 388 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

コネクテッドドラッグデリバリーデバイス市場規模は2023年に5兆1,234億5,000万米ドルとなり、2024年から2032年にかけてCAGR 23.5%で拡大します。

コネクテッドドラッグデリバリーデバイス市場：市場力学

スマートで効率的なドラッグデリバリーソリューションへの需要の高まり

糖尿病や喘息などの慢性疾患の増加により、コネクテッドドラッグデリバリーデバイスの需要が高まっています。これらのデバイスは、デジタルプラットフォームを通じてリアルタイムのモニタリング、リマインダー、フィードバックを提供することで、患者の服薬アドヒアランスを向上させます。個別化医療に対する意識の高まりと医療におけるIoTの統合が、これらの機器の採用をさらに後押ししています。ワイヤレス接続やモバイルアプリケーションなどの技術的進歩は、医療専門家の遠隔モニタリングを可能にすることで、治療成果を向上させる。さらに、スマート医療ソリューションへの投資の拡大と在宅ケアの推進が市場を活性化し、効果的かつ効率的な薬剤投与システムの世界のニーズに対応しています。

コネクテッドドラッグデリバリーデバイス市場：主な考察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間 (2024-2032年) に約23.5%のCAGRで毎年成長すると予測されています。

製品種類別では、統合型デバイスセグメントが2023年に最大の市場シェアを示すと予測されています。

用途別では、2023年に糖尿病セグメントが主要タイプでした。

地域別では、北米が2023年の売上高でトップ

コネクテッドドラッグデリバリーデバイス市場：セグメンテーション分析

コネクテッドドラッグデリバリーデバイスの世界市場は、製品タイプ、用途、投与経路、地域に基づいてセグメント化されます。市場は製品タイプにより3つに分類されます：スタンドアロン型コンポーネントとソフトウェア・統合デバイスです。コネクテッドドラッグデリバリー市場を独占しているのは統合デバイス分野です。これらのデバイスはドラッグデリバリー機構と内蔵の接続機能を組み合わせ、リアルタイムでのシームレスな追跡、モニタリング、データ共有を可能にします。その利便性、患者の服薬アドヒアランスの向上、デジタル医療システムへの統合機能が、広く普及する原動力となっています。個別化された効率的な薬剤投与への需要が高まる中、統合型デバイスは、特に糖尿病や喘息などの慢性疾患の管理において、医療プロバイダーや患者の間で好ましい選択肢となりつつあります。

投与経路別 (非経口投与、吸入投与)：コネクテッドドラッグデリバリーデバイス市場は、非経口投与セグメントが支配的です。糖尿病のような慢性疾患の有病率の高さと、コネクテッドインスリンペンのような自己投与デバイスの採用の増加が、この優位性を後押ししています。非経口投与デバイスは、正確な投与、使いやすさ、リアルタイムのデータ追跡による患者のコンプライアンス強化を提供します。さらに、注射ベースの送達を必要とする生物製剤の増加は、コネクテッド非経口デバイスの需要をさらに押し上げ、市場での主導的地位を確固たるものにしています。

用途別 (喘息、COPD、糖尿病管理、その他 (自己免疫疾患、多発性硬化症など))：糖尿病管理分野がコネクテッドドラッグデリバリーデバイス市場を独占しています。これは、世界の糖尿病有病率の上昇と、スマートインスリンペンとグルコースモニタリングシステムの採用増加によるものです。これらのデバイスは、治療計画の遵守率の向上、リアルタイムのモニタリング、データ共有機能を提供し、患者の転帰を向上させます。デジタルヘルス技術への投資が拡大し、個別化医療が重視される中、糖尿病管理は引き続き同市場の需要の大部分を牽引しています。

コネクテッドドラッグデリバリーデバイス市場：地域別分析

コネクテッドドラッグデリバリーデバイス市場は、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカで力強い成長を示しています。北米は、先進的な医療インフラ、デジタルヘルスソリューションの高い導入率、糖尿病や喘息などの慢性疾患の患者数の多さによりリードしています。欧州は、医療のデジタル化に多額の投資を行い、高齢者人口が増加しています。一方、アジア太平洋は、医療投資の増加、スマートフォンの利用率の上昇、コネクテッドデバイスへのアクセス拡大を背景に急成長を示しています。ラテンアメリカと中東・アフリカの新興国も、医療アクセスの改善により潜在力を発揮しています。

コネクテッドドラッグデリバリーデバイス市場：競合情勢

ドラッグデリバリーデバイス市場は競争が激しく、主要企業は技術革新と戦略的提携に注力しています。Propeller Health、Phillips-Medisize、Teva Pharmaceuticals、Adheriumなどの企業は、スマートテクノロジーを活用して患者のアドヒアランスとモニタリングを強化しています。製薬会社とハイテク企業の提携は、先進的な機器の開発を推進しています。新興企業もAI対応ソリューションで市場に参入しており、競争が激化しています。さらに、各社は規制要件を満たし、使い勝手を向上させるために研究開発に投資しています。慢性疾患の管理におけるコネクテッドデバイスの採用は、このダイナミックな市場での競争をさらに加速させています。

目次

第1章 コネクテッドドラッグデリバリーデバイス市場の概要

  • 調査範囲
  • 市場推定期間

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 コネクテッドドラッグデリバリーデバイスの主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 コネクテッドドラッグデリバリーデバイス市場：産業分析

  • PEST分析
  • ポーターのファイブフォース分析
  • 市場成長の見通し：マッピング
  • 規制体制の分析

第5章 コネクテッドドラッグデリバリーデバイス市場：高まる地政学的緊張の影響

  • COVID-19パンデミックの影響
  • ロシア・ウクライナ戦争の影響
  • 中東紛争の影響

第6章 コネクテッドドラッグデリバリーデバイスの市場情勢

  • コネクテッドドラッグデリバリーデバイスの市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 コネクテッドドラッグデリバリーデバイス市場：製品種類別

  • 概要
    • セグメントシェア分析：製品種類別
    • スタンドアロン型コンポーネント
    • ソフトウェア・統合デバイス

第8章 コネクテッドドラッグデリバリーデバイス市場：用途別

  • 概要
    • セグメントシェア分析：用途別
    • 慢性閉塞性肺疾患
    • 糖尿病管理
    • その他 (自己免疫疾患、多発性硬化症など)

第9章 コネクテッドドラッグデリバリーデバイス市場：投与経路別

  • 概要
    • セグメントシェア分析：投与経路別
    • 非経口
    • 吸入

第10章 コネクテッドドラッグデリバリーデバイス市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋 (APAC)
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析：コネクテッドドラッグデリバリーデバイス業界

  • 競合ダッシュボード
    • 競合ベンチマーク
    • 競合ポジショニング
  • 企業プロファイル
    • Phillips-Medisize (a Molex company)
    • BD (Becton, Dickinson and Company)
    • West Pharmaceutical Services, Inc.
    • Ypsomed AG
    • Novo Nordisk A/S
    • Propeller Health (a ResMed company)
    • Adherium Limited
    • Sensirion AG
    • Cohero Health (a Teva Pharmaceuticals subsidiary)
    • AptarGroup, Inc.
    • Others

第12章 AnalystViewの全方位的分析

目次
Product Code: ANV4330

REPORT HIGHLIGHT

Connected Drug Delivery Devices Market size was valued at USD 5,123.45 Billion in 2023, expanding at a CAGR of 23.5% from 2024 to 2032.

Connected drug delivery devices integrate advanced digital technology with traditional drug delivery systems to enhance patient care. These devices enable real-time monitoring, data sharing, and adherence tracking, offering personalized treatment options. Commonly used in chronic disease management, they support conditions like diabetes, asthma, and cardiovascular disorders. With features such as Bluetooth connectivity and smartphone integration, connected drug delivery devices improve therapeutic outcomes while empowering patients and healthcare providers with actionable insights for better disease management.

Connected Drug Delivery Devices Market- Market Dynamics

Increasing Demand for Smart and Efficient Drug Delivery Solutions

The increasing prevalence of chronic diseases, such as diabetes and asthma, is driving demand for connected drug delivery devices. These devices enhance patient adherence by providing real-time monitoring, reminders, and feedback through digital platforms. Rising awareness about personalized medicine and the integration of IoT in healthcare are further boosting their adoption. Technological advancements, including wireless connectivity and mobile applications, improve treatment outcomes by enabling remote monitoring for healthcare professionals. Additionally, growing investments in smart healthcare solutions and the push for home-based care are fueling the market, addressing the need for effective and efficient drug administration systems globally.

Connected Drug Delivery Devices Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 23.5% over the forecast period (2024-2032)

Based on Product Type segmentation, the integrated devices segment was predicted to show maximum market share in the year 2023

Based on application segmentation, the diabetes segment was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Connected Drug Delivery Devices Market- Segmentation Analysis:

The Global Connected Drug Delivery Devices Market is segmented based on Product Type, Application, Route of Administration, and Region. The market is divided into three categories based on Product Type: Standalone Components & Software and Integrated Devices. The Integrated Devices segment dominates the Connected Drug Delivery Devices Market. These devices combine drug delivery mechanisms with built-in connectivity features, enabling seamless tracking, monitoring, and data sharing in real-time. Their convenience, improved patient adherence, and ability to integrate into digital healthcare systems have driven widespread adoption. With the growing demand for personalized and efficient drug administration, integrated devices are becoming the preferred choice among healthcare providers and patients, particularly in managing chronic conditions like diabetes and asthma.

Based on route of administration: Parenteral and Inhalational. The parenteral segment dominates the Connected Drug Delivery Devices Market. The high prevalence of chronic diseases like diabetes and the increasing adoption of self-administration devices such as connected insulin pens drive this dominance. Parenteral devices offer precise dosing, ease of use, and enhanced patient compliance through real-time data tracking. Additionally, the rise in biologics requiring injection-based delivery further boosts demand for connected parenteral devices, solidifying their leading position in the market.

By application: Asthma, COPD, Diabetes Management and Others (autoimmune diseases, multiple sclerosis, etc.). The Diabetes Management segment dominates the Connected Drug Delivery Devices Market. This is attributed to the rising prevalence of diabetes globally and the increasing adoption of smart insulin pens and glucose monitoring systems. These devices offer improved adherence to treatment plans, real-time monitoring, and data sharing capabilities, enhancing patient outcomes. With growing investments in digital health technologies and a focus on personalized care, diabetes management continues to drive the majority of the demand in this market.

Connected Drug Delivery Devices Market- Geographical Insights

The Connected Drug Delivery Devices Market shows strong growth across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America leads due to its advanced healthcare infrastructure, high adoption rates of digital health solutions, and a large patient base for chronic conditions like diabetes and asthma. Europe follows with significant investments in healthcare digitalization and a growing elderly population. Meanwhile, Asia-Pacific exhibits rapid growth driven by increasing healthcare investments, rising smartphone usage, and expanding access to connected devices. Emerging economies in Latin America and the Middle East & Africa also display potential due to improving healthcare access.

Connected Drug Delivery Devices Market- Competitive Landscape:

The Connected Drug Delivery Devices Market is highly competitive, with key players focusing on innovation and strategic collaborations. Companies such as Propeller Health, Phillips-Medisize, Teva Pharmaceuticals, and Adherium are leveraging smart technology to enhance patient adherence and monitoring. Partnerships between pharmaceutical firms and tech companies are driving the development of advanced devices. Startups are also entering the market with AI-enabled solutions, intensifying competition. Additionally, players are investing in R&D to meet regulatory requirements and improve usability. The adoption of connected devices in managing chronic diseases is further accelerating competition in this dynamic market.

Recent Developments:

In February 2022, AptarGroup Inc. introduced the HeroTracker Sense, a digital solution that transforms traditional metered-dose inhalers into smart devices for enhanced medication management, particularly for asthma and COPD patients. This tool integrates with the BreatheSmart app, improving adherence and disease management.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Phillips-Medisize (a Molex company)
  • BD (Becton, Dickinson and Company)
  • West Pharmaceutical Services, Inc.
  • Ypsomed AG
  • Novo Nordisk A/S
  • Propeller Health (a ResMed company)
  • Adherium Limited
  • Sensirion AG
  • Cohero Health (a Teva Pharmaceuticals subsidiary)
  • AptarGroup, Inc.
  • Others

GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Standalone Components
  • Software and Integrated Devices

GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Asthma
  • COPD
  • Diabetes Management
  • Others (autoimmune diseases, multiple sclerosis, etc.)

GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

  • Parenteral
  • Inhalational

GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Connected Drug Delivery Devices Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Connected Drug Delivery Devices Market Snippet by Product Type
    • 2.1.2. Connected Drug Delivery Devices Market Snippet by Application
    • 2.1.3. Connected Drug Delivery Devices Market Snippet by Route of Administration
    • 2.1.4. Connected Drug Delivery Devices Market Snippet by Country
    • 2.1.5. Connected Drug Delivery Devices Market Snippet by Region
  • 2.2. Competitive Insights

3. Connected Drug Delivery Devices Key Market Trends

  • 3.1. Connected Drug Delivery Devices Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Connected Drug Delivery Devices Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Connected Drug Delivery Devices Market Opportunities
  • 3.4. Connected Drug Delivery Devices Market Future Trends

4. Connected Drug Delivery Devices Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Connected Drug Delivery Devices Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Connected Drug Delivery Devices Market Landscape

  • 6.1. Connected Drug Delivery Devices Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Connected Drug Delivery Devices Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Standalone Components
    • 7.1.3. Software and Integrated Devices

8. Connected Drug Delivery Devices Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. COPD
    • 8.1.3. Diabetes Management
    • 8.1.4. Others (autoimmune diseases, multiple sclerosis, etc.)

9. Connected Drug Delivery Devices Market - By Route of Administration

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Route of Administration, 2023 & 2032 (%)
    • 9.1.2. Parenteral
    • 9.1.3. Inhalational

10. Connected Drug Delivery Devices Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Connected Drug Delivery Devices Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Connected Drug Delivery Devices Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Connected Drug Delivery Devices Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Connected Drug Delivery Devices Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Connected Drug Delivery Devices Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Connected Drug Delivery Devices Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Phillips-Medisize (a Molex company)
    • 11.2.2. BD (Becton, Dickinson and Company)
    • 11.2.3. West Pharmaceutical Services, Inc.
    • 11.2.4. Ypsomed AG
    • 11.2.5. Novo Nordisk A/S
    • 11.2.6. Propeller Health (a ResMed company)
    • 11.2.7. Adherium Limited
    • 11.2.8. Sensirion AG
    • 11.2.9. Cohero Health (a Teva Pharmaceuticals subsidiary)
    • 11.2.10. AptarGroup, Inc.
    • 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us